Expansion of mesenchymal stem/stromal cells under xenogenic-free culture conditions

Advances in Biochemical Engineering/Biotechnology

Volumn 129, Issue , 2013, Pages 33-57

  Kinzebach, Sven ^a   Bieback, Karen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Chemically defined medium; Fetal bovine serum; Human serum; Mesenchymal stem cells; Mesenchymal stromal cells; Platelet lysate; Serum free medium; Standardization; Xenogenic free medium

Indexed keywords

ANIMAL; ARTICLE; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; METHODOLOGY; SERUM;

ANIMALS; CELL CULTURE TECHNIQUES; CULTURE MEDIA; HUMANS; MESENCHYMAL STROMAL CELLS; SERUM;

EID: 84878141180     PISSN: 07246145     EISSN: None     Source Type: Book Series    
DOI: 10.1007/10_2012_134     Document Type: Article

References (103)

1. Agata H, Watanabe N, Ishii Y et al (2009) Feasibility and efficacy of bone tissue engineering using human bone marrow stromal cells cultivated in serum-free conditions. Biochem Biophys Res Commun 382:353-358
2. Arthur A, Zannettino A, Gronthos S (2009) The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J Cell Physiol 218:237-245
3. Astori G, Soncin S, Lo Cicero V et al (2010) Bone marrow derived stem cells in regenerative medicine as advanced therapy medicinal products. Am J Transl Res 2:285-295
4. Avanzini MA, Bernardo ME, Cometa AM et al (2009) Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood-and bone marrow-derived progenitors. Haematologica 94:1649-1660
5. Belford DA, Rogers ML, Regester GO et al (1995) Milk-derived growth factors as serum supplements for the growth of fibroblast and epithelial cells. In Vitro Cell Dev Biol Anim 31:752-760
6. Bernardo ME, Avanzini MA, Perotti C et al (2007) Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol 211:121-130
7. Bernardo ME, Cometa AM, Pagliara D et al (2011) Ex vivo expansion of mesenchymal stromal cells. Best Pract Res Clin Haematol 24:73-81
8. Bernardo ME, Pagliara D, Locatelli F (2012) Mesenchymal stromal cell therapy: a revolution in regenerative medicine? Bone Marrow Transplant 47:164-171
9. Bieback K, Ha VA, Hecker A et al (2010) Altered gene expression in human adipose stem cells cultured with fetal bovine serum compared to human supplements. Tissue Eng Part A 16:3467-3484
10. Bieback K, Hecker A, Kocaomer A et al (2009) Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27:2331-2341
11. Bieback K, Hecker A, Schlechter T et al (2012) Replicative aging and differentiation potential of human adipose tissue-derived mesenchymal stromal cells expanded in pooled human or fetal bovine serum. Cytotherapy
12. Bieback K, Kinzebach S, Karagianni M (2011) Translating research into clinical scale manufacturing of mesenchymal stromal cells. Stem Cells Int 2010:193519
13. Bieback K, Schallmoser K, Klüter H et al (2008) Clinical protocols for the isolation and expansion of mesenchymal stromal cells. Transfus Med Hemother 35:286-294
14. Breitbach M, Bostani T, Roell W et al (2007) Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110:1362-1369
15. Bruder SP, Jaiswal N, Haynesworth SE (1997) Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64:278-294
16. Brunner D, Frank J, Appl H et al (2010) Serum-free cell culture: the serum-free media interactive online database. ALTEX 27:53-62
17. Burns JS, Abdallah BM, Guldberg P et al (2005) Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res 65:3126-3135
18. Caplan AI (1991) Mesenchymal stem cells. J Orthop Res 9:641-650
19. Caplan AI (1994) The mesengenic process. Clin Plast Surg 21:429-435
20. Caplan AI, Correa D (2011) The MSC: an injury drugstore. Cell Stem Cell 9:11-15
21. Chase LG, Lakshmipathy U, Solchaga LA, Rao MS, Vemuri MC (2010) A novel serum-free medium for the expansion of human mesenchymal stem cells: Stem Cell Res Ther 1:8
22. Chatzistamatiou T, Kokkinos T, Papassavas A, Stavropoulos-Giokas C (2007) Cord blood serum: an efficient media supplement for maintaining cord blood derived mesenchymal stem cells cultures. Tissue Antigens. 65:524-525
23. Cheng H, Qiu L, Ma J et al (2011) Replicative senescence of human bone marrow and umbilical cord derived mesenchymal stem cells and their differentiation to adipocytes and osteoblasts. Mol Biol Rep 38:5161-5168
24. Crespo-Diaz R, Behfar A, Butler GW et al (2011) Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. Cell Transplant 20:797-811
25. Dahl JA, Duggal S, Coulston N et al (2008) Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum. Int J Dev Biol 52:1033-1042
26. Deans RJ, Moseley AB (2000) Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28:875-884
27. Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8:315-317
28. Doucet C, Ernou I, Zhang Y et al (2005) Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205:228-236
29. Dugrillon A, Eichler H, Kern S et al (2002) Autologous concentrated platelet-rich plasma (cprp) for local application in bone regeneration. Int J Oral Maxillofac Surg 31:615-619
30. Eastment CT, Sirbasku DA (1980) Human platelet lysate contains growth factor activities for established cell lines derived from various tissues of several species. In Vitro 16:694-705
31. EMEA (2003) Note for guidance on the use of bovine serum in the manufacture of human medicinal products. EMEA CPMP/BWP/1793/02.
32. Fan X, Liu T, Liu Y et al (2009) Optimization of primary culture condition for mesenchymal stem cells derived fromumbilical cord bloodwith factorial design. Biotechnol Prog 25:499-507
33. Fekete N, Gadelorge M, Furst D, Maurer C, Dausend J, Fleury-Cappellesso S, Mailander V, Lotfi R, Ignatius A, Sensebe L, Bourin P, Schrezenmeier H, Rojewski MT (2012) Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components. Cytotherapy 14:540-554
34. Filipic B, Shehata M, Toth S et al (2002) Novel serum replacement based on bovine ocular fluid: a useful tool for cultivation of different animal cells in vitro. ALTEX 19:15-20
35. Friedenstein AJ, Deriglasova UF, Kulagina NN et al (1974) Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2:83-92
36. Friedenstein AJ, Petrakova KV, Kurolesova AI et al (1968) Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6:230-247
37. Gastens MH, Goltry K, Prohaska W et al (2007) Good manufacturing practice-compliant expansion of marrow-derived stem and progenitor cells for cell therapy. Cell Transplant 16:685-696
38. Gronthos S, Simmons PJ (1995) The growth factor requirements of stro-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 85:929-940
39. Gruber R, Karreth F, Kandler B et al (2004) Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets 15:29-35
40. Hartmann I, Hollweck T, Haffner S et al (2010) Umbilical cord tissue-derived mesenchymal stem cells grow best under gmp-compliant culture conditions and maintain their phenotypic and functional properties. J Immunol Methods 363:80-89
41. Heiskanen A, Satomaa T, Tiitinen S et al (2007) N-Glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells 25:197-202
42. Honn KV, Singley JA, Chavin W (1975) Fetal bovine serum: a multivariate standard. Proc Soc Exp Biol Med 149:344-347
43. Horwitz EM, Le Blanc K, Dominici M et al (2005) Clarification of the nomenclature for MSC: the international society for cellular therapy position statement. Cytotherapy 7:393-395
44. Horwitz EM, Prockop DJ, Fitzpatrick LA et al (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5:309-313
45. Horwitz EM, Prockop DJ, Gordon PL et al (2001) Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97:1227-1231
46. Hosseinkhani H, Hosseinkhani M, Kobayashi H (2006) Proliferation and differentiation of mesenchymal stem cells using self-assembled peptide amphiphile nanofibers. Biomed Mater 1:8-15
47. Ito K, Yamada Y, Nagasaka T et al (2005) Osteogenic potential of injectable tissueengineered bone: a comparison among autogenous bone, bone substitute (bio-Oss), plateletrich plasma, and tissue-engineered bone with respect to their mechanical properties and histological findings. J Biomed Mater Res A 73:63-72
48. Janetzko K, Bugert P (2011) Pathogen reduction in blood products: what's behind these techniques? Transfus Med Hemother 38:5-6
49. Jung J, Moon N, Ahn JY et al (2009) Mesenchymal stromal cells expanded in human allogenic cord blood serum display higher self-renewal and enhanced osteogenic potential. Stem Cells Dev 18:559-571
50. Kilian O, Flesch I, Wenisch S et al (2004) Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro. Eur J Med Res 9:337-344
51. Klopp AH, Gupta A, Spaeth E et al (2011) Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells 29:11-19
52. Kobayashi T, Watanabe H, Yanagawa T et al (2005) Motility and growth of human bonemarrow mesenchymal stem cells during ex vivo expansion in autologous serum. J Bone Joint Surg Br 87:1426-1433
53. Koc ON, Gerson SL, Cooper BW et al (2000) Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18:307-316
54. Kocaoemer A, Kern S, Klüter H et al (2007) Human ab serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25:1270-1278
55. Ksiazek K (2009) A comprehensive review on mesenchymal stem cell growth and senescence. Rejuvenation Res 12:105-116
56. Lange C, Cakiroglu F, Spiess AN et al (2007) Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 213:18-26
57. Lazennec G, Jorgensen C (2008) Concise review: adult multipotent stromal cells and cancer: risk or benefit? Stem Cells 26:1387-1394
58. Le Blanc K, Frassoni F, Ball L et al (2008) Mesenchymal stem cells for treatment of steroidresistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371:1579-1586
59. Le Blanc K, Rasmusson I, Sundberg B et al (2004) Treatment of severe acute graft-versushost disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441
60. Le Blanc K, Samuelsson H, Gustafsson B et al (2007) Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 21:1733-1738
61. Le Blanc K, Tammik L, Sundberg B et al (2003) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57:11-20
62. Lepperdinger G, Brunauer R, Jamnig A et al (2008) Controversial issue: is it safe to employ mesenchymal stem cells in cell-based therapies? Exp Gerontol 43:1018-1023
63. Lin HT, Tarng YW, Chen YC et al (2005) Using human plasma supplemented medium to cultivate human bone marrow-derived mesenchymal stem cell and evaluation of its multiple-lineage potential. Transplant Proc 37:4504-4505
64. Mannello F, Tonti GA (2007) Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: Conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells 25:1603-1609
65. Marx RE (2004) Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62:489-496
66. Mizuno N, Shiba H, Ozeki Y et al (2006) Human autologous serum obtained using a completely closed bag system as a substitute for foetal calf serum in human mesenchymal stem cell cultures. Cell Biol Int 30:521-524
67. Muller AM, Davenport M, Verrier S et al (2009) Platelet lysate as a serum substitute for 2D static and 3D perfusion culture of stromal vascular fraction cells from human adipose tissue. Tissue Eng Part A 15:869-875
68. Ng F, Boucher S, Koh S et al (2008) PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 112:295-307
69. Nimura A, Muneta T, Koga H et al (2008) Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum. Arthritis Rheum 58:501-510
70. Pakkanen R (1994) Bovine colostrum ultrafiltrate supplemented with adult bovine serum and transferrin: an effective fbs substitute for cultivation of Vero and CHO-K1 cells. In Vitro Cell Dev Biol Anim 30A:295-299
71. Pazos P, Boveri M, Gennari A et al (2004) Culturing cells without serum: lessons learnt using molecules of plant origin. ALTEX 21:67-72
72. Perez-Ilzarbe M, Diez-Campelo M, Aranda P et al (2009) Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy. Transfusion 49:1901-1910
73. Pevsner-Fischer M, Levin S, Zipori D (2011) The origins of mesenchymal stromal cell heterogeneity. Stem Cell Rev 7:560-568
74. Phadnis SM, Joglekar MV, Venkateshan V et al (2006) Human umbilical cord blood serum promotes growth, proliferation, as well as differentiation of human bone marrow-derived progenitor cells. In Vitro Cell Dev Biol Anim 42:283-286
75. Phermthai T, Odglun Y, Chuenwattana P et al (2011) Successful derivation and characteristics of xeno-free mesenchymal stem cell lines from human amniotic fluid generated under allogenic cord blood serum supplementation. Tissue Eng Regen Med 8:216-223
76. Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
77. Prockop DJ (2007) "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin Pharmacol Ther 82:241-243
78. Prockop DJ, Brenner M, Fibbe WE et al (2010) Defining the risks of mesenchymal stromal cell therapy. Cytotherapy 12:576-578
79. Ramasamy R, Lam EW, Soeiro I et al (2007) Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia 21:304-310
80. Schafer R, Schnaidt M, Klaffschenkel RA et al (2011) Expression of blood group genes by mesenchymal stem cells. Br J Haematol 153:520-528
81. Schallmoser K, Bartmann C, Rohde E et al (2007) Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47:1436-1446
82. Schallmoser K, Rohde E, Bartmann C et al (2009) Platelet-derived growth factors for GMPcompliant propagation of mesenchymal stromal cells. Biomed Mater Eng 19:271-276
83. Selvaggi TA, Walker RE, Fleisher TA (1997) Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 89:776-779
84. Sensebe L (2008) Clinical grade production of mesenchymal stem cells. Biomed Mater Eng 18:S3-S10
85. Sensebe L, Krampera M, Schrezenmeier H, Bourin P, Giordano R (2010) Mesenchymal stem cells for clinical application. Vox Sang 98:93-107
86. Senzel L, Gnatenko DV, Bahou WF (2009) The platelet proteome. Curr Opin Hematol 16:329-333
87. Shahdadfar A, Fronsdal K, Haug T et al (2005) In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem cells 23:1357-1366
88. Shetty P, Bharucha K, Tanavde V (2007) Human umbilical cord blood serum can replace fetal bovine serum in the culture of mesenchymal stem cells. Cell Biol Int 31:293-298
89. Shibata KR, Aoyama T, Shima Y et al (2007) Expression of the p16ink4a gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion. Stem Cells 25:2371-2382
90. Shih DT, Chen JC, Chen WY et al (2011) Expansion of adipose tissue mesenchymal stromal progenitors in serum-free medium supplemented with virally inactivated allogeneic human platelet lysate. Transfusion 51:770-778
91. Song HJ, Zhang P, Guo XJ et al (2009) The proteomic analysis of human neonatal umbilical cord serum by mass spectrometry. Acta Pharmacologica Sinica 30:1550-1558
92. Spees JL, Gregory CA, Singh H et al (2004) Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 9:747-756
93. Stute N, Holtz K, Bubenheim M et al (2004) Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 32:1212-1225
94. Sundin M, Ringden O, Sundberg B et al (2007) No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 92:1208-1215
95. Tarte K, Gaillard J, Lataillade JJ, Fouillard L, Becker M, Mossafa H, Tchirkov A, Rouard H, Henry C, Splingard M, Dulong J, Monnier D, Gourmelon P, Gorin NC, Sensebe L (2010) Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 115:1549-1553
96. Tekkatte C, Gunasingh GP, Cherian KM et al (2011) "Humanized" Stem cell culture techniques: the animal serum controversy. Stem Cells Int 2011:504723
97. Turnovcova K, Ruzickova K, Vanecek V et al (2009) Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media. Cytotherapy 11:874-885
98. van der Valk J, Brunner D, De Smet K et al (2010) Optimization of chemically defined cell culture media-replacing fetal bovine serum in mammalian in vitro methods. Toxicol In Vitro 24:1053-1063
99. von Bonin M, Stolzel F, Goedecke A et al (2009) Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant 43:245-251
100. Weissman IL (2000) Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 287:1442-1446
101. Wessman SJ, Levings RL (1999) Benefits and risks due to animal serum used in cell culture production. Dev Biol Stand 99:3-8
102. Yang C, Frei H, Rossi FM et al (2009) The differential in vitro and in vivo responses of bone marrow stromal cells on novel porous gelatin-alginate scaffolds. J Tissue Eng Regen Med 3:601-614
103. Zeisberger SM, Schulz JC, Mairhofer M et al (2011) Biological and physicochemical characterization of a serum-and xeno-free chemically defined cryopreservation procedure for adult human progenitor cells. Cell transplant 20:1241-1257